| Partner |
Project |
Available |
Contact |
| Uni Tuebingen, Medical Genetics |
Generation and characterization of a humanized ASYN PD mouse model |
no |
Olaf.Riess(at)med.uni-tuebingen.de |
| Uni Tuebingen, Hertie Institute |
Influence of ASYN aggregation on cognitive neurotransmission |
no |
Philipp.kahle(at)uni-tuebingen.de |
| BRFAA |
ASYN and the lysosomes: A complicated relationship |
no |
lstefanis(at)bioacademy.gr |
| IMM Lisbon |
ASYN function and dysfunction: the role of post-translational modifications |
no |
touteiro(at)gmail.com |
| Uni Aarhus |
Binding of ASYN oligomers to cellular targets – a toxic embrace |
no |
phj(at)biokemi.au.dk |
| Uni Lund |
Critical factors affecting the toxicity of ASYN in vivo |
no |
Deniz.Kirik(at)med.lu.se |
| Bioalvo |
ASYN and tau: dangerous liaisons |
no |
Patricia.calado(at)bioalvo.com |
| Farfield |
Development of a toolbox for the structural characterization of ASYN monomer and oligomer interactions |
no |
mswann(at)farfield-group.com |
| Boehringer Ingelheim |
ASYN: the role of lysosomal degradation |
no |
thomas.ciossek(at)boehringer-ingelheim.com |
| MPI |
Structure, interactions and detection of ASYN oligomers |
no |
mazw(at)nmr.mpibpc(at)mpg.de |
| Uni Lancaster |
Oligomers of ASYN as a biomarker for human disease |
no |
d.allsop(at)lancaster.ac.uk |
